Skip to content Skip to footer

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

67 articles published Follow:
Real-Life Science

From Idea to Impact: AI Use Cases That Delivered Real-Life Sciences Business Results

Introduction Artificial Intelligence is redefining healthcare and life sciences. From improving patient care to accelerating drug discovery, AI is proving to be more than just a technological trend; it’s a critical enabler of innovation and efficiency. In this article, we explore real-world AI applications in clinical studies, pharmacovigilance, diagnostics, and medical operations. These use cases…

Read More

Unlock the ROI of GenAI-Enabled Literature Reviews

Unlock the ROI of GenAI-Enabled Literature Reviews

Traditional literature reviews are slow, expensive, and resource-heavy. MadeAi™ makes literature reviews fast and efficient with MadeAi-LR. MadeAi-LR harnesses GenAI to streamline evidence synthesis, accelerating timelines while maintaining rigor and transparency. With both self-service and full-service options, MadeAi-LR helps life sciences teams cut workload, reduce costs, and deliver high-quality results faster. Download Unlock the ROI…

Read More

AI in Evidence Generation

How HTA Agencies Are Evaluating AI in Evidence Generation

As AI rapidly reshapes the evidence landscape, health technology assessment (HTA) bodies are beginning to define clear expectations for its use in submissions. At CapeStart, we work closely with life sciences clients navigating these changes—especially those integrating GenAI into literature reviews, RWE generation, economic modeling, Joint Clinical Assessment (JCA) support, Clinical Evaluation Reports (CERs), Patient…

Read More

Stevie Award

CapeStart MadeAi™ GenAI Platform Wins a Stevie® Award in 2025 International Business Awards® for the Second Year in a Row

Newest version of MadeAi™ for content synthesis hailed by judges as “a significant leap in applying Generative AI to the life sciences”   Cambridge, MA, August 25, 2025—CapeStart, an AI solutions and services firm, announced that its CapeStart MadeAi™ GenAI Platform for Life Sciences Content Synthesis was a winner of a Stevie® Award in The…

Read More

webinar

Which New LLM Is Better for Life Sciences? – CapeStart Exclusive Webinar On-Demand

Missed our live session? Get the recording now! On July 11, 2025, CapeStart hosted a 30-minute webinar comparing three leading large language models—Gemini 2.5 Pro, GPT-o3, and Claude Sonnet 4—to see which performs best for screening, reasoning, and summarization in life sciences workflows. Designed for both technical leads and non-technical decision-makers, the session shared real-world…

Read More